Dried flower is the largest part of this young cannabis market by units and by value, but investors can’t afford to ignore the oil market.
The Health Canada data is out, so we took a fresh look at the retail product sample to try and evaluate the bulk market. Stay tuned for oil.
Canopy’s June quarter didn’t give us any indication that they’re ready to create cannabis at margin or make a jump to a reasonable rate of growth.
The market is catching on to paper factory Supreme Cannabis’ board using the company treasury to bail out their other cannabis startups while the usual suspects are busy running interference.
These touts can’t be foolish enough to attack @mollytime777 and @thecannalysts… $CANN they?
$CURA gets some nasty mail from the government. FH looks at the risk to $CWEB, $IAN, $LHS & $TRUL
No bottom in sight for Canntrust (TSX:TRST)(NYSE:CTST), and they deserve it. Fundamental Hype on the Canntrust smoking gun. Short Canopy (TSX:WEED)(NYSE:CGC), long Organigram(TSX.V:OGI)(NASDAQ:OGI), and we’re going to tell you why.
We’ve got a dire outlook on $CTST $TRST. Feat. cannabis media all-stars @BettingBruiser & @VanmalaS
The near term prospects for a Linton-less $WEED $CGC don’t look good.